Business
Appointment of Interim Finance Director
Appointment of Interim Finance Director.
About this update from Abingdon Health Plc
[{"type":"text","content":"\n\n \n \nAbingdon Health plc\n(\"Abingdon Health\" or \"the Company\")\n \nAppointment of Interim Finance Director\n \nYork, U.K. 24 October 2023: Abingdon Health plc (AIM: ABDX, 'Abingdon' or 'the Company'), a leading international lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), announces that Mr Andrew Feather has been appointed Interim Finance Director (non-Board) with immediate effect.\n \nAndrew has over 25 years' experience in financial management as a seasoned interim finance director. His previous interim experience at companies in or serving the healthcare and life sciences sectors includes senior roles at Carclo plc, Tecomet Symmetry Medical Ltd, Covidien and Neoss Limited. Andrew is a qualified Chartered Management Accountant.\n \nInitially, Andrew will work with Mrs Melanie Ross, CFO, during a handover period until Melanie leaves Abingdon on 30 November 2023.\n \nEnquiries\n\n\n\n\nAbingdon Health plc\n\n\nwww.abingdonhealth.com/investors/\n\n\n\n\nChris Yates, Chief Executive Officer\n\n\nVia Walbrook PR\n\n\n\n\nChris Hand, Non-Executive Chairman\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nSinger Capital Markets (Sole Broker and Nominated Adviser)\n\n\nTel: +44 (0)20 7496 3000\n\n\n\n\nPeter Steel, Alex Bond (Corporate Finance)\n\n\n \n\n\n\n\nTom Salvesen (Corporate Broking)\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n\nWalbrook PR Limited\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Phillip Marriage\nAlice Woodings\n\n\nMob: +44 (0)7980 541 893 / +44 (0)7867 984 082\n+44 (0)7407 804 654\n\n\n\n\n\n\n\n\n\n \nAbout Abingdon Health plc\nAbingdon Health is a leading lateral flow contract research (CRO) and contract development and manufacturing organisation (\"CDMO\") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from \"idea to commercial success.\"\nThe Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfe...